Akorn Inc.
2500 Millbrook Drive
Buffalo Grove,
IL 60089
United States - Map
Phone: 847-279-6100
Fax: 847-279-6123
Web Site: http://www.akorn.com
| Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in the areas of ophthalmology, rheumatology, anesthesia, and antidotes in the United States. The companys Ophthalmic Segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are used in the office setting. It also sells therapeutic products, such as antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers and other national account customers. In addition, this segment offers non-pharmaceutical products, including various artificial tear solutions, preservative-free lubricating ointments, eyelid cleansers, vitamin supplements, and contact lens accessories. The companys Hospital Drugs and Injectables Segment markets specialty injectable pharmaceutical products, including antidotes and anesthesia, as well as products used in the treatment of rheumatoid arthritis and pain management. It markets products to hospitals through wholesalers and other national account customers, as well as directly to medical specialists. The companys Biologics and Vaccines Segment markets adult Tetanus-Diphtheria vaccines directly to hospitals and physicians, as well as through wholesalers and national distributors. Its Contract Services Segment manufactures products for third party pharmaceutical and biotechnology customers. The company also markets and distributes vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, and other pharmaceutical companies. The company has strategic partnerships with Strides Arcolab Limited; Serum Institute of India, Ltd.; Hameln Pharmaceuticals; and Cipla, Ltd. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Mark M. Silverberg , 55
Exec. VP of Operations, Global Quality Assurance & Technical Services |
$
236.00K |
$
0 | Mr. John R. Sabat , 59
Sr. VP of National Accounts and Trade Relations |
$
213.00K |
$
0 | Mr. Raj Rai , 42
Interim Chief Exec. Officer and Strategic Consultant |
N/A
| N/A | Mr. Timothy A. Dick , 39
Chief Financial Officer |
N/A
| N/A | Dr. Sam Boddapati Ph.D.,
Sr. VP of Regulatory Affairs |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.47% Nasdaq 
Profile
